Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: a case report by Onal, Cem et al.
Case report
Open Access
Bilateral glomus tumor treated with PET-CT based conformal
radiotherapy: a case report
Cem Onal*, Oznur Yuksel, Erkan Topkan and Berrin Pehlivan
Address: Department of Radiation Oncology, Baskent University Medical Faculty, 01120, Adana, Turkey
Email: CO* - hcemonal@hotmail.com; OY - droznuryuksel@hotmail.com; ET - drerkantopkan@yahoo.com; BP - berrin_pehlivan@yahoo.com
*Corresponding author
Received: 23 June 2009 Accepted: 31 August 2009 Published: 15 September 2009
Cases Journal 2009, 2:8402 doi: 10.4076/1757-1626-2-8402
This article is available from: http://casesjournal.com/casesjournal/article/view/8402
© 2009 Onal et al.; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Glomus tumors are benign, slow growing tumors originating from paraganglionic
tissue, mostly located at the carotid bifurcation, jugular foramen, cervical portion vagus nerve, and
middle ear cavity. Radiotherapy is treatment of choice for patients with intracranial extension, and
patients with bilateral and multiple tumors, or patients who are inoperable.
Case presentation: We present a 53-year-old female patient with a glomus tumor treated with
positron emission tomography computed tomography planning and 3D conformal radiotherapy, and
the patient has remained free of disease progression 2 years after.
Conclusion: It is suggested that radiotherapy is a good treatment modality in patients with glomus
tumor, and metabolic imaging and treatment planning with positron emission tomography computed
tomography is superior to other imaging modalities.
Introduction
Glomus tumors (GT), also named as paragangliomas and
chemodectomas are rare tumors, accounting for 0.03% of
all neoplasms and 0.6% of all head and neck tumors [1].
These benign, slow-growing tumors originate from para-
ganglionic tissue, mostly located at the carotid bifurcation,
jugular foramen, cervical portion vagus nerve, and middle
ear cavity [2,3]. Typically, these tumors are diagnosed
between the fourth and sixth decades of life. Women are
affected five to six times more often than men. The most
common presentation is painless neck mass.
Familial occurrence is likely to occur in 10% of patients,
with an autosomal dominant inheritance. Multiple
tumors are seen in 78-87% of familial paragangliomas,
and the incidence of bilateral GT is 32% for familial cases
and 4% for non-familial cases [4].
To our knowledge, we report thefirst case of a non-familial
bilateral GT treated with Positron Emission Tomography
(PET) based 3D conformal radiotherapy (RT), and
treatment response assessed with PET.
Case presentation
A 53-year-old Turkish female patient presented with
bilateral neck masses for 10 years, which had been
increased in size for the last 6 months. Patient was
complaining about a moderate hearing loss and tinnitus
Page 1 of 4
(page number not for citation purposes)on the left ear, and pain at the left side of the neck, besides
no hoarseness, dysphagia, nasal obstruction and epistaxis
were reported. There are no symptoms related with the
carotid artery compression. No family history of glomus
tumors or any cancers was present. On physical examina-
tion, semi-mobile, painless masses with a size of
approximately 4 × 3 cm on the right side of the neck,
and 8 × 6 cm mass extending from tip of mastoid to level
IV inferiorly on the left side were palpated. On systemic
evaluation only hypertension diagnosed for 3 years which
was under control with medications. 24-hour vanilman-
delic acid (VMA) levels and other endocrinologic findings
were found to be normal. The magnetic resonance (MRI)
studies revealed highly vascularised, intensely enhanced,
hypointense and isointense with surrounding muscles
5 cm mass on the left carotid bifurcation compressing
jugulary vein and carotid artery, and 2.5 cm mass at the left
side (Figures 1a, 1b). Cervical Magnetic Resonance
Angiography (MRA) demonstrated a 4 × 6 cm mass at
the left carotid bifurcation level which compresses the
external carotid artery, and a mass with similar character-
istics at the right carotid bifurcation (Figure 2a). The
internal carotid artery flow at both sides was found to be
normal (Figure 2b). On 18F-2-deoxy-D-glucose (FDG)
PET-CT, a 6 × 4 cm mass extending from submandibular
region to para-laryngeal field at the left side (SUVmax:
9.9), and a 3 × 2.3 cm mass at the right side of the neck
(SUVmax : 8.5) (Figure 3). Also an additional 15 mm mass
(SUVmax: 28.3) at the celiac truncus level in front of the
abdominal aorta was identified besides the bilateral
cervical masses (Figure 4). Since MRI and PET findings
strongly were correlated with glomus tumor, and there was
a high risk of bleeding, tissue diagnosis was not obtained.
Patient had no gain with medical treatment and embolisa-
tion, and the masses were increased in size within last
6 months of period. Since the tumors are located at both
sides of the neck, and are close to the vascular structures,
the surgeons did not decide to make any surgical
procedure; we treated the patient with 3D conformal
radiotherapy with a total dose of 50 Gy with 2 Gy
fractional daily doses with PET-CT planning. During
treatment, acute ‘Radiation Therapy Oncology Group’
(RTOG) Grade II dysphagia and Grade I dry desquamation
at neck were seen, which were clarified with adequate
medications. At 6th month the pain at the neck region
totally disappeared and loss of hearing and the tinnitus at
left ear diminished. The PET-CT taken at last visit, revealed
a 5 × 4 cm with necrosis at the central part (SUVmax: 7.7)
at left side, and a 2 × 2 cm mass (SUVmax: 2.5) at right
side of the neck (Figure 5). The patient is still in follow-up
and had clinically and radiological stable disease with no
complaints after 2 years.
Figure 1. Axial T1-weighted magnetic resonance imaging
(MRI) scans. (a) A 5 cm hypointense and isointense with
muscle mass on the left carotid bifurcation compressing
jugulary vein and carotid artery and 2.5 cm mass at the
left side. (b) These masses intensely enhance contrast.
Figure 2. (a) Magnetic resonance angiography (MRA)
demonstrated a mass at the left carotid bifurcation
compressing the external carotid artery, and a mass with
similar characteristics at the right carotid bifurcation.
(b) Lateral angiographic view reveals an intense blush of
hypervascular mass.
Figure 3. FDG-Positron Emission Tomography (PET) CT
scans showed a mass at the left side (SUVmax: 9.9), and
mass at the right side of the neck (SUVmax: 8.5).
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Glomus tumors are mainly presented in two locations;
cervical (carotid, vagal) and skull base (jugular and
tympanic) [5]. These tumors are rarely seen, and have
benign characteristics and a very slow growth rate of 1 mm
per year [5]. The initial diagnosis is usually non-tender
neck mass, in case of rapid growth or increase in size,
because of compression to the surrounding structures,
pain, hoarseness, disphagia may develop. Our patient had
bilateral neck masses for the last 10 years and a moderate
tenderness around the masses because of rapid growth for
last 6 months.
CT and MRI are useful diagnostic tools for assessing
suspicious paraganglioma. CT can reveal the invasion of
the bony structures and intracranial extension, while MRI
is better for evaluating vascular structures, extension along
neural foramina, and detecting multicentricity [6].
The characteristic appearance of GT in MRI is well-
defined hypointense mass with equal signal intensity to
adjacent muscle on T1-weighted scans. Intense contrast
enhancement is the key finding on MRI. MRA is less
invasive diagnostic tool for evaluation of vascular structure
of the tumor. With 3D time-of-flight technique, the
specificity and sensitivity of MRA was 90% and 92% [7].
Another tool used for diagnosis of GT is PET-CT. Previous
reports demonstrated that paragangliomas show uptake of
FDG [8,9]. The main advantages of PET-CT are, the
metabolic activity of smaller lesions (<1 cm) can be
detected with PET-CT, and also with whole body detection
it is possible for the proof or exclusion of multifocal or
metastatic tumors [10]. In our case, since there was high
risk of bleeding, and the patient was inoperable, MRA and
FDG-PET were performed for confirmation of diagnosis.
M e a n w h i l e ,w ew e r es u s p i c i o u se v e ni ft h e r ew a s
metastasis or multicentricity, with FDG-PET we detected
a nodular lesion at the preaortic region. Also we used PET-
CT scans for treatment planning for better target volume
delineation.
The optimum management of GT still remains controver-
sial. The treatment options are surgery, RT and watchful
waiting. Since the metastasis rate is rare, the main aim of
treatment choice is to achieve good local control without
increasing morbidity and mortality.Local treatment canbe
achieved with either surgically as total removal or long-
term tumor control and tumor shrinkage with RT.
Although good results were achieved with complete
surgical removal and total excision with microsurgical
approach can often be accomplished, there is a significant
risk of morbidity (0-39%) and mortality (0-2.7%) with
this approach [11-13]. Radiotherapy is treatment of choice
for patients with intracranial extension, and patients with
bilateral and multiple tumors, or patients who are
inoperable [4,14]. Although the mechanism of growth
inhibition of GT is not well understood, vascular elements
that comprise the bulk of tumor undergo fibrosis after RT.
Furthermore, the tumor (chief) cells are radioresistant and
persist after RT [15]. Local tumor control rates were
61-94%, and reported rates of symptom improvement was
71-89% with RT alone [16,17]. It is important to note that
the goal of RT is disease control or growth inhibition
rather than tumor elimination. Complication rates after
RT range from 4% to 10% including dermatitis, mucositis,
external otitis and otitis media, altered taste and xerosto-
mia, which often resolve with medication [14,16,17].
Since we made 3D conformal RT, we spare normal tissues
better than conventional plan. Only dysphagia and dry
desquamation were seen during treatment, which resolved
with proper medications.
Glomus tumors respond to RT slowly. Residual mass
persisting after RT does not indicate treatment failure.
Tumor may decrease in size, but rarely disappears. Disease
control is defined as the absence of progression of
symptoms without any increase in size with physical
Figure 4. FDG-Positron Emission Tomography (PET) CT
scans showed a mass (SUVmax: 28.3) detected at the celiac
truncus level in front of the abdominal aorta (arrow).
Figure 5. FDG-Positron Emission Tomography (PET) CT
scans showed a mass at the left side with necrosis at the
central part (SUVmax: 7.7) and a mass (SUVmax: 2.5) at
right side of the neck after radiotherapy.
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can be used for evaluation of the metabolic response after
treatment. Argiris et al. demonstrated good metabolic
response with PET scan in patient with metastatic
paraganglioma treated with chemotherapy [8], but RT
response with PET was not presented previously. We firstly
demonstrated a good metabolic response with FDG PET-
CT after 2 years of RT.
Conclusion
Glomus tumors are slow-growing lesions; therefore, it is
necessary to be cautious about tumor control without
increasing morbidity and mortality. Radiotherapy has
become a primary treatment modality for GT in patients
with unresectable symptomatic tumors, and bilateral
tumors, in which, a good local control and reasonable
tumor shrinkage was achieved in our case. Also we
propose that FDG PET seems to be a promosing procedure
for diagnosis and treatment response of GTs.
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